Desk›Healthcare› Haleos Labs Ltd
Haleos Labs Ltd
BSE 540679 · NSE HALEOSLABS · ISIN INE320X01016 · Group B · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹1,542.00
+2.97%
BSE close, 28 August 2026
₹466.19 cr
0.3 cr shares · Micro cap
₹130.03 cr
as published
29.4× · 2.48×
EPS ₹52.45 · BV ₹621.77
300.99 / 17.78
₹ cr, as filed
18
1 selected · 6%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -13.3% |
|---|---|
| Against 52-week low | +42.2% |
| Day change | +2.97% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹52.45 |
|---|---|
| Price / earnings | 29.40× |
| Price / book | 2.48× |
| Book value — derived, price ÷ P/B | ₹621.77 |
| Return on equity | 8.43% |
| Operating margin | 14.89% |
| Net margin | 4.77% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 8.44%
- ROE as published
- 8.43%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 67.83 | 3.24 | 10.71 | 14.89% | 4.77% |
| Mar-26 · Q | 63.38 | 2.24 | 7.39 | 11.31% | 3.53% |
| FY25-26 | 300.99 | 17.78 | 58.80 | 13.92% | 5.91% |
Quarter on quarter
- Revenue, quarter on quarter
- +7.0%
- Net profit, quarter on quarter
- +44.6%
- Operating margin, quarter on quarter
- +358 bps
Disclosure profile 18 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Selected sub-total | 1 |
| Procedural | |
| General | 9 |
| AGM / EGM | 3 |
| Postal Ballot | 3 |
| Annual Report | 1 |
| Trading Window | 1 |
| Procedural sub-total | 17 |
| Total | 18 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
18 filings · 1 selected · busiest 2026-08-05 and 2026-09-08
Filing rhythm · the twelve most recent
2026-08-072026-10-01
SelectedProcedural
Filings
18 in the window · 3 earlier on record
-
1 October 2026 ·
-
30 September 2026 ·
-
21 September 2026 ·
Closure of Trading Window
Intimation of Closure of Trading Window.
Insider Trading / SAST / Closure of Trading Window View filing →
-
18 September 2026 ·
USFDA Update (Material Subsidiary)
Update on the material subsidiary of the Company.
Company Update / General View filing →
-
9 September 2026 ·
Annual Report (Weblink)
Communication to physical shareholders providing them with the link to the Annual Report and AGM Notice.
Company Update / General View filing →
-
8 September 2026 ·
Newspaper Advertisement (AGM Notice)
Enclosed newspaper advertisement for the AGM Notice.
Company Update / General View filing →
-
8 September 2026 ·
-
8 September 2026 ·
Reg. 34 (1) Annual Report.
Enclosed Annual Report for the year ended 31st March, 2026.
Others / Reg. 34 (1) Annual Report View filing →
-
1 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
Outcome of Postal Ballot.
AGM/EGM / Postal Ballot View filing →
-
1 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Outcome of Board meeting.
AGM/EGM / Postal Ballot View filing →
-
24 August 2026 ·
Communication To Shareholders (TDS Related)
Enclosed email communication sent to Shareholders.
Company Update / General View filing →
-
7 August 2026 ·
Newspaper Publication (Financial Results)
Enclosed -- newspaper advertisement for Q1F27 results.
Company Update / General View filing →
-
5 August 2026 ·
Update (Material Subsidiary)
Mahi Drugs Private Limited appointed Cost Auditors for the year 2026-27 and Mr. Vincent P Asrao as Nominee Director.
Company Update / General View filing →
-
5 August 2026 ·
Independent Directors (Reappointed)
Dr. Mannam Malakondaiah and Dr. Srinivas Samavedam were reappointed for a second term of 5 years w.e.f. November 13, 2026, subject to approval of shareholders.
Company Update / General View filing →
-
5 August 2026 ·
Board Meeting Outcome for Meeting Held On Aug 5, 2026
Enclosed - Outcome of 98th Board meeting.
Board Meeting / Outcome of Board Meeting View filing →
-
30 July 2026 ·
Newspaper Publication (Postal Ballot)
Enclosed - Newspaper advertisement.
Company Update / General View filing →
-
29 July 2026 ·
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Postal Ballot Notice (30.07.2026 to 28.08.2026)
AGM/EGM / Postal Ballot View filing →
-
29 July 2026 ·
Events Calendar (Postal Ballot)
Enclosed: events calendar for the Postal Ballot.
Company Update / General View filing →
RSS feed for Haleos Labs Ltd · the 50 most recent filings